Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Screening for mast cell activation disorders including systemic mastocytosis
<5,205 pg/mg creatinine
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Elevated levels of 2,3-dinor-11beta-prostaglandin F2 alpha (2,3 BPG) in urine are not specific for systemic mast cell disease and may be found in patients with angioedema, diffuse urticaria, or myeloproliferative diseases in the absence of diffuse mast cell proliferation
3 - 8 days
Collect urine in a plastic container. Send to Specimen Processing refrigerated.
Test performed by Mayo Clinic Laboratories